Flyer: Science vs ‘Misinformation’ – Censorship vs Debate?

References

1. The Risks of Covid Vaccinations Exceed the Benefits
   Fraiman, J., Erviti, J., Jones, M., Greenland, S., Whelan, P., Kaplan, R. M., & Doshi, P. (2022). Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults. Vaccine, 40(40), 5798–5805.
   View Study – Secondary evaluation of Pfizer and Moderna’s original approval trials shows more adverse events in the vaccinated group than in the placebo group.
2. Pharmaceutical Industry Funding for Medsafe and TGA
   James, C. (2023). Response to your request for official information. Retrieved from Medsafe OIA Response;
   Demasi, M. (2022). From FDA to MHRA: are drug regulators for hire? BMJ, 377, o1538.
   View Study – In the 2022-23 year, Medsafe received 84.05% of its funding from the pharmaceutical industry, while Australia’s TGA was funded 96% by the same sources.
3. The “20 Million Lives Saved” Claim – A Closer Look
   Denis G. Rancourt, et al. (2024). Spatiotemporal variation of excess all-cause mortality in the world during the Covid period 2020-2023. CORRELATION Research in the Public Interest, Report.
   View Study – This comprehensive report argues that more lives were lost than saved by the Covid vaccine, challenging claims based on mathematical modeling.
4. Myocardial Inflammation Post-Vaccination
   Nakahara, T., et al. (2023). Assessment of Myocardial 18F-FDG Uptake at PET/CT in Asymptomatic SARS-CoV-2–vaccinated and Nonvaccinated Patients. Radiology, 308(3), e230743.
   View Study – Specialized scans reveal that all patients who received two mRNA-based Covid vaccines showed abnormal cardiomyocyte metabolism.
5. Covid-19 Vaccination and Disease Course Worsening
   Uusküla, A., et al. (2023). Risk of SARS-CoV-2 infection and hospitalization in individuals with natural, vaccine-induced and hybrid immunity. Scientific Reports, 13(1), 20347. View Study 
   Irrgang, P., et al. (2023). Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination. Science Immunology, 8(79), eade2798. View Study 
   – Individuals with vaccine-induced immunity may face a higher risk of infection and hospitalization than those with natural immunity, with studies suggesting a shift to less effective antibodies post-vaccination.
6. Vaccination in Pregnancy: Medsafe’s Stance
   Medsafe. (2024). New Zealand Data Sheet Comirnaty.
   View Document – Medsafe has never broadly recommended the Covid-19 vaccine for all pregnant women, advising its use only when the benefits outweigh potential risks.
7. DNA Contamination in Pfizer Vaccines
   McKernan, K., et al. (2023). Sequencing of bivalent Moderna and Pfizer mRNA vaccines reveals nanogram to microgram quantities of expression vector dsDNA per dose.  View Study
    Aldén, M., et al. (2022). Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line. Current Issues in Molecular Biology, 44(3), 1115–1126. View Study
   – Findings of plasmid DNA in vaccine vials raise questions about manufacturing safety and potential health risks, including gene integration into the human genome.
8. Understanding Relative and Absolute Risk Reduction in Pfizer’s Vaccine
   Polack, F. P., et al. (2020). Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. The New England Journal of Medicine, 383(27), 2603–2615.
   View Study – The Relative Risk Reduction (RRR) was 95%, but the Absolute Risk Reduction (ARR) was only 0.84%, offering a more nuanced understanding of vaccine efficacy.
   Learn More About RRR vs. ARR